CVN-293 is an oral, brain-penetrant, small-molecule inhibitor of KCNK13.
For research use only. We do not sell to patients.
Name | CVN-293 |
---|---|
Iupac Chemical Name | 4-(7-fluoro-1-(pyridazin-3-ylmethyl)-1H-benzo[d]imidazol-2-yl)-1,2,5-oxadiazol-3-amine |
Synonyms | CVN-293 ; CVN293 ; CVN 293 |
Molecular Formula | C14H10FN7O |
Molecular Weight | 311.27 |
Smile | NC1=NON=C1C2=NC3=CC=CC(F)=C3N2CC4=NN=CC=C4 |
InChiKey | ONRXHVJHFORDDI-UHFFFAOYSA-N |
InChi | InChI=1S/C14H10FN7O/c15-9-4-1-5-10-12(9)22(7-8-3-2-6-17-19-8)14(18-10)11-13(16)21-23-20-11/h1-6H,7H2,(H2,16,21) |
CAS Number | 2815296-08-1 |
Related CAS | 2815296-08-1 |
Packaging | Price | Availability | Purity | Shipping Time |
---|---|---|---|---|
Bulk | Enquiry | Enquiry | Enquiry |
Formulation | Solid powder |
---|---|
Purity | ≧98.0% |
Storage | Dry, dark and at 0 - 4℃ for short term (days to weeks) or -20℃ for long term (months to years). |
Solubility | Soluble in DMSO (DMSO : ≥ 100 mg/mL) |
Handling | Refer to MSDS |
Shipping Condition | Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs. |
HS Code | 2934200090 |
Targets | |
---|---|
Mechanism | |
Cell study | |
Animal study | |
Clinical study |